Diverse Platforms
Leading Drug Delivery
Our in-house facility is equipped with advanced nanotechnologies for liposome and lipid nanoparticle (LNP) drug delivery and development. Our experienced team specializes in designing, formulating, and optimizing liposomal and LNP-based drug delivery systems for various applications. Our comprehensive services include formulation development, characterization, scale-up, and process optimization, tailored to your specific needs. With our expertise, resources, and infrastructure, we accelerate your projects, reduce scale-up risks, and enhance the bioavailability, stability, and efficacy of your drugs.
Transdermal Delivery
TransE, a novel cell-penetrating peptide that enhances skin absorption of large biomolecules. TransE exhibits the ability to penetrate deeper layers of skin tissue and transport larger molecules, providing a significant advancement in the field of non-invasive, needle-free, and pain-free treatments.
Cancer Immunotherapy
Cellax is a nanotechnology that controls the release of water-insoluble drugs to tumors, increasing drug delivery to the tumor microenvironment, leading to tumor regression, and extended survival. It can be used alone or in combination with other therapies to improve treatment efficacy, including immune-cold tumors, by depleting cancer-associated fibroblasts.
Targeted Cancer Stroma Delivery
TransE, a novel cell-penetrating peptide that enhances skin absorption of large biomolecules. TransE exhibits the ability to penetrate deeper layers of skin tissue and transport larger molecules, providing a significant advancement in the field of non-invasive, needle-free, and pain-free treatments.
Pediatric Formulation
We introduce new taste-masking tech for children’s medicine, making it easier for them to take their medicine without the unpleasant taste. This technology has been rigorously tested and proven effective in improving medication compliance, leading to better health outcomes. (Case #4)
More Cases Available
